Quaker Chemical SEC Filings

Gulf Hungary Holding and its subsidiary QH Hungary Holdings filed Amendment No. 40 to update their Schedule 13D on Quaker Chemical Corporation common stock. They continue to beneficially own a total of 3,640,129 shares, representing about 21.0% of the outstanding common stock, based on 17,366,444 shares outstanding as of April 27, 2026.

QH Hungary directly owns 3,635,112 shares, many of which are pledged under margin loan and prepaid variable share forward arrangements with Citibank and Royal Bank of Canada, while Gulf Hungary directly owns an additional 5,017 escrowed shares. On May 26, 2026, QH Hungary amended and restated multiple prepaid variable share forward supplemental confirmations with Citibank and RBC, paying $4,228,368 to Citibank and $445,539 to RBC in exchange for revised terms.

The updated contracts cover specified maximum share amounts and give QH Hungary the option at each future settlement date (generally between June 1, 2028 and July 7, 2028 for certain tranches) to deliver Quaker Chemical shares or the cash equivalent, with the exact number of shares determined by formulas tied to volume-weighted average prices, a floor price of $141.84 per share and cap prices around $156.02 per share.

QH Hungary Holdings Ltd, a 10% owner of Quaker Chemical Corp, reported a series of derivative transactions involving Variable Prepaid Forward Sale Contracts on May 26, 2026. These contracts reference an aggregate of 341,612 shares of Quaker Chemical common stock.

All nine entries are coded as "J" transactions, described as "other acquisition or disposition" of derivative securities and classified as restructuring events, with no open‑market buys or sells reported. The filing shows no net share purchases or sales, only structural changes in derivative positions linked to the common stock.

Gulf Hungary Holding Korlatolt Felelossegu Tarsasag, a more than 10% owner of Quaker Chemical Corp, reported nine derivative transactions involving Variable Prepaid Forward Sale Contracts tied to an aggregate of 341,612 shares of common stock. Each transaction is coded “J” as an “other acquisition or disposition” and classified as a restructuring event, with no open-market purchases or sales reported. The interests are held indirectly through QH Hungary Holdings Limited.

Quaker Chemical Corporation announced that long-time director and Chairman Michael F. Barry will retire from the Board after the May 13, 2026 meeting. The Board reduced its size from eleven to ten directors and elected independent director Mark A. Douglas as the new Chairman, eliminating the Lead Director role. Shareholders elected three directors for terms ending in 2029, approved on an advisory basis the compensation of named executive officers, and ratified PricewaterhouseCoopers LLP as independent auditor for fiscal 2026. The company also issued a press release honoring Mr. Barry’s contributions and outlining related governance changes.

Quaker Chemical Corporation reported higher results for the first quarter of 2026, with net sales of $480.5 million, up 8% from $442.9 million a year earlier. Growth came from roughly 3% higher organic volumes, about 4% from acquisitions, and a 4% favorable currency impact, partly offset by a 3% decline in selling price and product mix.

Net income rose to $19.7 million, or $1.13 diluted EPS, from $12.9 million, or $0.73, while non-GAAP net income was $28.4 million and non-GAAP diluted EPS was $1.63 versus $28.0 million and $1.58. Adjusted EBITDA increased to $72.5 million from $69.0 million as gross margin improved to 36.8%. Operating cash flow turned positive at $3.8 million versus a $3.1 million outflow, and cash ended at $169.7 million against total borrowings of $875.0 million. The company launched a 2026 global business transformation program targeting at least $20–$30 million of annualized cost savings, while continuing its 2022 cost program, and noted that Middle East geopolitical tensions have not yet had a material financial impact but pose ongoing supply chain and cost risks.

Quaker Houghton reported stronger first-quarter 2026 results with higher sales and profit. Net sales were $480.5 million, up 8% from $442.9 million a year earlier, helped by 3% higher volumes, 4% growth from acquisitions and favorable currency, partly offset by lower pricing and mix.

Net income rose to $19.7 million, or $1.13 per diluted share, compared with $12.9 million, or $0.73 per share, while non-GAAP net income was $28.4 million and non-GAAP diluted EPS was $1.63, slightly above $1.58 last year. Adjusted EBITDA increased 5% to $72.5 million.

Asia/Pacific led growth with 25% higher sales, EMEA grew 10% and Americas was flat year over year. Operating cash flow improved to $3.8 million from a $3.1 million outflow. The company ended March 31, 2026 with $875.0 million of gross debt, $169.7 million of cash and a net debt-to-trailing adjusted EBITDA ratio of about 2.3x.

Quaker Houghton amended its credit agreement after quarter-end, extending the nearest maturity to 2031 and increasing available credit, and launched a global transformation and cost program targeting $20 million to $30 million of annualized savings by 2028, with a $10 million run-rate goal by the end of 2026.

Quaker Chemical Corp ownership disclosure: Vanguard Portfolio Management reports beneficial ownership of 934,704 shares of Common Stock, representing 5.39% of the class as of 03/31/2026. Vanguard shows sole dispositive power over 934,704 shares and sole voting power for 5,291 shares, and states holdings include shares held for Vanguard funds and managed accounts.

Quaker Houghton entered into an amended senior secured credit agreement that refinances its existing facilities, extends debt maturities and increases available borrowing capacity. The new package includes a $550 million U.S. dollar term loan, a $250 million-equivalent euro term loan and an $800 million revolving credit facility, all maturing in 2031. Proceeds repaid the prior credit agreement and support working capital, strategic growth and other capital allocation plans. The facility is secured by first‑priority liens on substantially all assets of the company and certain subsidiaries, and includes leverage and interest coverage covenants plus limits on additional debt, acquisitions, dividends, buybacks and other restricted payments.

Meagher Kevin K. reported acquisition or exercise transactions in this Form 4 filing.

Quaker Chemical Corp VP Kevin K. Meagher reported an amended insider transaction reflecting a compensation grant of 445 Restricted Stock Units (RSUs) tied to the company’s common stock. This corrects a previously reported grant of 297 RSUs. Each RSU represents a contingent right to receive one share of KWR common stock.

The RSUs were granted under the company’s Long-Term Performance Incentive Plan and will vest in three annual installments beginning on March 15, 2027. Dividend Equivalent Rights accrue on these RSUs when and as dividends are paid on Quaker Chemical common stock.